Price to Sales ratio Analysis of Tekla Healthcare Investors - Deep Dive
Latest FY PS
Period Ending - Sep-23
Very Poor PS
14.09
Period Ending - Sep-22
Very Poor PS
-3.83
Growth
467.86 %
Trailing Twelve Months PS
Period Ending - Sep-23
Very Poor PS
9.73
PS Analysis of Tekla Healthcare Investors
P/S Ratio of Tekla Healthcare Investors with value of 9.73 indicates that stock price is high compared to sales of the company and may be overvalued. |
PS Ratio of HQH rose handsomely by 467.86 % this year. |
PS Ratio with value of 14.09 was highest in Year Sep-23 in last Five Years. |
PS Ratio with value of -4.75 was lowest in Year Sep-19 in last Five Years. |
Latest PS Ratio with value of 14.09 is Greater than Average PS of 2.64 in last five years. |
Other PS Related Info of HQH that may interest you.
Tekla Healthcare Investors Overview
Code | Price | Previous Price | Price Change | Sector |
---|---|---|---|---|
HQH | 16.56 | 16.4 | 0.976 % | Asset Management |
Defination of Price to Sales
The Price to Sales Ratio indicates how much investors are willing to pay for each rupee of sales generated by a company. Price-to-Sales Ratio is used to determine whether a stock is currently profitable or less profitable, which is helpful for better investment decisions. more ..PS Related Ratios
PriceToBookRatio | PriceToEarningRatio | AssetTurnoverRatio |
Tsr Value Index
Very Low Value Stock |
FY - Historical Price to Sales of Tekla Healthcare Investors
Period | Sep-23 | Sep-22 | Sep-21 | Sep-20 | Sep-19 | Sep-18 | Sep-17 |
---|---|---|---|---|---|---|---|
PS | 14.09 | -3.83 | 4.69 | 3.02 | -4.75 | 10.55 | 5.46 |
Change | 467.86 % | -181.71 % | 55.34 % | 163.58 % | -144.96 % | 93.35 % | -95.94 % |
FY Chart of Price to Sales of Tekla Healthcare Investors
Note : All Data Generated at the End of Trading Hours (EOD Data)